A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome
Journal of Artificial Organs · 2025
DOI: 10.1007/s10047-024-01455-x ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Artificial Organs, 2025. Verfasst von Makiko Nakamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan. Hauptthemen laut MEDLINE: Myocarditis, Myelodysplastic Syndromes, Heart-Assist Devices, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
We encountered a 64-year-old woman who experienced fulminant myocarditis and underwent treatment with veno-arterial extracorporeal membrane oxygenation and Impella CP support. Subsequently, she underwent a device upgrade to Impella 5.5 and received continuous hemodiafiltration for 3 months. During mechanical circulatory support, she developed refractory anemia and thrombocytopenia, leading to a diagnosis of myelodysplastic syndrome. Following the removal of the devices, she no longer required blood transfusions. She received HeartMate 3 left ventricular assist device implantation as a destination therapy indication despite the presence of myelodysplastic syndrome. She was successfully managed by aspirin-free antithrombotic therapy without any hemocompatibility-related adverse events for 4 months after index discharge on foot. We present a patient with a unique and rare presentation, wherein HeartMate 3 was implanted and successfully managed without aspirin to prevent bleeding complications associated with myelodysplastic syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan.
- The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan. teimamu@med.u-toyama.ac.jp.
- Department of Cardiovascular Surgery, University of Toyama, Toyama, Toyama, Japan.
Zitieren
APA
Nakamura, M., Imamura, T., Hida, Y., Izumida, T., Nakagaito, M., Nagura, S., Doi, T., Fukahara, K., & Kinugawa, K. (2025). A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome. Journal of Artificial Organs. https://doi.org/10.1007/s10047-024-01455-x
Vancouver
Nakamura M, Imamura T, Hida Y, Izumida T, Nakagaito M, Nagura S, et al. A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome. Journal of Artificial Organs. 2025. doi:10.1007/s10047-024-01455-x
BibTeX
@article{Nakamura2025,
author = {Nakamura, Makiko and Imamura, Teruhiko and Hida, Yuki and Izumida, Toshihide and Nakagaito, Masaki and Nagura, Saori and Doi, Toshio and Fukahara, Kazuaki and Kinugawa, Koichiro},
title = {A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome},
journal = {Journal of Artificial Organs},
year = {2025},
doi = {10.1007/s10047-024-01455-x}
}
EUVIMED